Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
July 24 2024 - 7:00AM
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company
committed to advancing new standards of care for the frontline
treatment of hematologic malignancies, today announced that it will
host a live conference call and webcast at 8:30 a.m. ET on
Wednesday, July 31, 2024 to report its second quarter 2024
financial results and provide a business update.
To access the live conference call, please dial (800) 549-8228
(domestic) or (289) 819-1520 (international) and refer to
conference ID 64947. A webcast of the call will also be available
on the Investors & Media section of the Syros website at
www.syros.com. An archived replay of the webcast will be available
for approximately 30 days following the call.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the
frontline treatment of patients with hematologic malignancies.
Driven by the motivation to help patients with blood disorders that
have largely eluded other targeted approaches, Syros is developing
tamibarotene, an oral selective RARĪ± agonist in frontline patients
with higher-risk myelodysplastic syndrome and acute myeloid
leukemia with RARA gene overexpression. For more information, visit
www.syros.com and follow us on Twitter (@SyrosPharma) and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240724051062/en/
Syros Karen Hunady Director of Corporate Communications
& Investor Relations 1-857-327-7321 khunady@syros.com
Investor Amanda Isacoff Precision AQ 212-362-1200
amanda.isacoff@precisionaq.com
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Dec 2023 to Dec 2024
